Airtel Payments Bank Appoints Anuj Bansal as CFO
Airtel Payments Bank has announced the appointment of Anuj Bansal as the Chief Financial Officer (CFO).
Cognizant CEO Ravi Kumar Joins the Board of USISPF
The US-India Strategic Partnership Forum (USISPF) has announced that Ravi Kumar S., the current Chief Executive Officer (CEO) of Cognizant, will be appointed to its Board of Directors.
3M Appoints Bill Brown as New CEO
3M, the industrial conglomerate (MMM.N), has appointed William M. "Bill" Brown, former CEO of L3Harris Technologies, as its next Chief Executive Officer (CEO).
3M’s Amit Laroya Appointed Independent Director at Kennametal
The Board of Kennametal India Limited appointed Amit Laroya as an Additional Director in the category of Non-Executive and Independent Director, with effect from March 11, 2024.
Puravankara’s Executive Director Nani R. Choksey Resigned
Nani R. Choksey, Executive Director of Puravankara Limited, has tendered his resignation from the Board of Directors of the company with effect from March 11, 2024.
DHL’s Namita Patwari Appointed as VP HR at Alembic Pharmaceuticals
Namita Patwari is appointed as Vice President, Human Resources, and Senior Management Personnel of Alembic Pharmaceuticals Limited, with effect from March 11, 2024.
Wanbury’s Independent Director Pallavi Shedge Retired
Pallavi Prakash Shedge retired from the post of Independent Director on completion of her second term at Wanbury Limited, with effect from February 13, 2024.
Tata Investment Appoints Savitha Narayanan as CTO & Jenniefer Samuel as Head of Internal Audit
The Board of Directors of Tata Investment Corporation Limited has approved the appointment of Savitha Narayanan as Chief Technology Officer for three years, with effect from April 1, 2024.
J.B. Chemicals & Pharmaceuticals’ Chairman & Independent Director Ranjit Shahani Passes Away
J.B. Chemicals & Pharmaceuticals Limited has announced the sad demise of Ranjit Shahani, Chairman and Non-Executive, Independent Director of the company, on March 9, 2024.
Astec Lifesciences Reappoints Anurag Roy as CEO
On March 9, 2024, shareholders of Astec Lifesciences Limited approved the reappointment of Anurag Roy as the whole-time Director and Chief Executive Officer for three years, with effect from July 28, 2024.